Skip to content

Effect of Melatonin on Feeding Intolerance and Incidence of Necrotizing Enterocolitis in Preterm Infants

Effect of Melatonin on Feeding Intolerance and Incidence of Necrotizing Enterocolitis in Preterm Infants

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04304807
Enrollment
90
Registered
2020-03-11
Start date
2018-12-24
Completion date
2019-12-31
Last updated
2020-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Infant, Feeding Intolerance, Necrotizing Enterocolitis

Brief summary

Assesses the efficacy of melatonin in treatment of feeding intolerance in preterm infants, the time needed to reach full enteral intake, the incidence of necrotizing enterocolitis and measures the level of tumor necrosis factor-alpha as a marker of oxidative stress.

Detailed description

This is a prospective study held on ninety preterm infants in Ain Shams University neonatal intensive care units. All enrolled neonates were suffering from feeding intolerance in the form of abdominal distension, gastric residuals or bloody stools. The first group of forty five infants were given melatonin in addition to traditional antibiotic treatment. The second group of forty five infants were given traditional antibiotic treatment only. Both groups were followed up clinically as regards improvement of clinical signs of feeding intolerance and laboratory results till they reached full enteral intake. Both groups were compared as regards incidence of necrotizing enterocolitis and level of tumor necrosis factor-alpha after 72 hours of starting treatment as a marker of oxidative stress.

Interventions

Melatonin was given as a total dose of 20 mg via enteral route in two doses of 10 mg each with a 1 hour interval in between.

DRUGTraditional antibiotic treatment

Traditional antibiotic treatment was given to both groups with feeding intolerance according to treatment protocols by neonatal intensive care units of Ain Shams University

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Preterm infants (\<37 weeks of gestation) * Evidence of feeding intolerance

Exclusion criteria

* Infants with hypoxic ischemic encephalopathy * Infants on nothing per os * Infants with high oxygen needs wither on invasive or non-invasive mechanical ventilation * Major congenital anomalies * Intracranial hemorrhage * Respiratory distress syndrome

Design outcomes

Primary

MeasureTime frameDescription
Melatonin as an antioxidant and free radical scavenger in feeding intolerance in preterm infants3 daysMelatonin efficacy in treatment of oxidative stress in preterm infants with feeding intolerance was assessed by measuring level of tumor necrosis factor- alpha.
Melatonin efficacy in reducing incidence of necrotizing enterocolitis in preterm infants1 weekMelatonin efficacy in reducing incidence of necrotizing enterocolitis by radiological criteria: abdominal ultrasound showing pneumatosis intestinalis.
Effect of melatonin on time needed to reach full enteral intake in preterm infants with feeding intolerance2 weeksPreterm infants with feeding intolerance were observed for the time needed to reach full enteral intake.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026